Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDPI
11401
DELISTED
Superior Drilling Products Inc.
SDPI
| $36.8K | ﹤0.01% |
+29,919
| New | +$31.7K |
|
|
AIM
11402
AIM ImmunoTech
AIM
$7.73M
| $36.6K | ﹤0.01% |
547
+447
| +447% | +$21.6K |
|
11403
PUT
SelectQuote
SLQT
$96.6M
| $36.5K | ﹤0.01% |
+18,700
| New | +$31.5K |
|
11404
Galectin Therapeutics
GALT
$419M
| $36.4K | ﹤0.01% |
25,285
-5,044
| -17% | -$8.55K |
|
|
BTLN
11405
PUT
Brightline Interactive
BTLN
$20.8M
| $36.3K | ﹤0.01% |
10,200
| – | – |
|
|
PVL
11406
PUT
Permianville Royalty Trust
PVL
$60.1M
| $36.3K | ﹤0.01% |
+14,500
| New | +$36.7K |
|
11407
CALL
Angi Inc
ANGI
$191M
| $36K | ﹤0.01% |
1,090
-1,580
| -59% | -$44.2K |
|
11408
PUT
Summit Therapeutics
SMMT
$11.4B
| $35.9K | ﹤0.01% |
14,300
-210,100
| -94% | -$383K |
|
11409
Research Frontiers
REFR
$16.9M
| $35.8K | ﹤0.01% |
+22,356
| New | +$36.1K |
|
11410
GEE Group
JOB
$28M
| $35.7K | ﹤0.01% |
+69,676
| New | +$33.8K |
|
|
ZEPP
11411
Zepp Health
ZEPP
$77.3M
| $35.6K | ﹤0.01% |
7,810
-2,214
| -22% | -$11.2K |
|
11412
Clene
CLNN
$57.6M
| $35.6K | ﹤0.01% |
+2,023
| New | +$39.5K |
|
11413
Cocrystal Pharma
COCP
$22.3M
| $35.6K | ﹤0.01% |
14,897
-5,831
| -28% | -$14.2K |
|
11414
NanoViricides
NNVC
$32.4M
| $35.4K | ﹤0.01% |
30,777
+16,624
| +117% | +$20.1K |
|
|
11415
CALL
Clene
CLNN
$57.6M
| $35.2K | ﹤0.01% |
2,000
+710
| +55% | +$13.9K |
|
11416
CALL
MediciNova
MNOV
$70.9M
| $35.2K | ﹤0.01% |
+15,300
| New | +$33.7K |
|
11417
PUT
MarketWise
MKTW
$49.3M
| $35K | ﹤0.01% |
875
-255
| -23% | -$10K |
|
|
GRTS
11418
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $34.9K | ﹤0.01% |
17,900
-22,500
| -56% | -$52.7K |
|
|
ASTR
11419
CALL
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $34.8K | ﹤0.01% |
6,273
-20
| -0.3% | -$114 |
|
|
LVTX
11420
CALL
DELISTED
LAVA Therapeutics
LVTX
| $34.7K | ﹤0.01% |
+17,100
| New | +$31.6K |
|
11421
CALL
Cerus
CERS
$552M
| $34.7K | ﹤0.01% |
14,100
-42,300
| -75% | -$101K |
|
11422
AEye
LIDR
$56.3M
| $34.7K | ﹤0.01% |
6,414
+4,775
| +291% | +$29.6K |
|
11423
PUT
FreightCar America
RAIL
$237M
| $34.6K | ﹤0.01% |
+11,600
| New | +$33.5K |
|
11424
CALL
RAVE Restaurant Group
RAVE
$44.2M
| $34.5K | ﹤0.01% |
17,100
-2,400
| -12% | -$3.98K |
|
11425
CALL
Clear Channel Outdoor Holdings
CCO
$1.21B
| $34.5K | ﹤0.01% |
25,200
-25,600
| -50% | -$31.9K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.